Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266
Wall Street
Price Targets
Price Targets Summary
Suzhou Zelgen Biopharmaceuticals Co Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Suzhou Zelgen Biopharmaceuticals Co Ltd's stock price target?
Not Available
Suzhou Zelgen Biopharmaceuticals Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Suzhou Zelgen Biopharmaceuticals Co Ltd's Revenue forecast?
Projected CAGR
68%
The compound annual growth rate of Suzhou Zelgen Biopharmaceuticals Co Ltd's revenue for the next 3 years is 68%.